C. Kent Osborne, M.D. - Funding
P50 CA58183 (Osborne) 9/30/92 - Nov. 11, 2008 - 34 percent
SPORE in Breast Cancer
The major goal of this large Specialized Program of Resource Excellence is to expedite the translation of basic research into applied clinical applications in breast cancer detection, treatment and prevention.
P01 CA30195 (Osborne) 8/1/97 - Dec. 31, 2003 - 0 percent
Markers of Breast Cancer Evolution and Progression
The major goal of this large Program Project is to identify prognostic factors for making treatment decisions and the most effective methods for integrating them into clinically useful models. This Program Project was extended for a year without additional funds.
DAM.D. 17-02-1-0288 (Osborne) July 1, 2002 - June 31, 2005 - 10 percent
The Signaling Intermediate and Estrogen Receptor Co-Repressor FKHR in the Pathogenesis of Breast Cancer
The major goals of this project are to map FKHR's functional domains and to evaluate the importance of FKHR in normal mammary gland development.
P01 CA30195 (Osborne) Dec. 12, 2003 - Nov. 30, 2008 - 25 percent
Novel Gene Networks in Breast Development and Cancer
The major goals of this large Program Project are to identify and characterize the role of novel genetic pathways, which are found to be important in the normal breast, in the pathogenesis and progression of human breast cancer.
There is no scientific or budgetary overlap.